Palisade Bio closes $138 million public offering to fund drug trial Oct 2, 2025 04:05PM
Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option Oct 2, 2025 04:05PM